Lennox-Gastaut syndrome: a comprehensive review

@article{AsadiPooya2017LennoxGastautSA,
  title={Lennox-Gastaut syndrome: a comprehensive review},
  author={Ali Akbar Asadi-Pooya},
  journal={Neurological Sciences},
  year={2017},
  volume={39},
  pages={403-414}
}
Lennox-Gastaut syndrome (LGS) is considered an epileptic encephalopathy and is defined by a triad of multiple drug-resistant seizure types, a specific EEG pattern showing bursts of slow spike-wave complexes or generalized paroxysmal fast activity, and intellectual disability. The prevalence of LGS is estimated between 1 and 2% of all patients with epilepsy. The etiology of LGS is often divided into two groups: identifiable (genetic-structural-metabolic) in 65 to 75% of the patients and LGS of… Expand
The pharmacological management of Lennox-Gastaut syndrome and critical literature review
TLDR
Currently, cannabidiol has provided high evidence of efficacy against LGS seizures; however, these data must be confirmed by long-term extensive studies and by trials comparing different AEDs, one to each other. Expand
Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review
TLDR
Effective management of Lennox-Gastaut syndrome requires a broader perspective to not only control seizures but improve the quality of life by addressing cognitive and behavioral problems, sleep disturbances, physical disability, social disability, and educational and employment challenges. Expand
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies
TLDR
Six treatments are specifically indicated as adjunct therapies for the treatment of seizures associated with LGS in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate and most recently cannabidiol, which have demonstrated reductions in drop seizures in 15%–68% of patients across trials. Expand
Lennox-Gastaut Syndrome: In a Nutshell
TLDR
Various pharmacological and surgical procedures have been proposed for the treatment of Lennox-Gastaut syndrome and many more to come in the very near future to overcome the drug resistance and to avoid the patient forming a life-long dependency. Expand
The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
TLDR
An eight-year-old boy presenting to the emergency department with seizures and mental retardation is reported, diagnosed with LGS with concomitant ASD and successfully been treated for his treatment-resistant seizures. Expand
The unchanging face of Lennox-Gastaut syndrome in adulthood
TLDR
Paying attention to all factors of seizure outcomes, cognitive impairment, and ambulatory status, all patients were dependent on caregivers for daily living abilities, and LGS has life-long persistence with poor outcomes, even during adulthood. Expand
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
TLDR
The use of adjunctive RFN in children and adolescents with LGS and its efficacy and safety profile, based on a systematic literature review, shows a very favorable profile in terms of adverse events and drug-interactions. Expand
[Why the diagnosis of Lennox-Gastaut syndrome is a rare one?]
TLDR
D diagnosis of the syndrome is complicated by its polyetiology (clinical and EEG manifestations can vary significantly), the evolution of seizure types and EEG characteristics as the patient matures, the presence of other epileptic syndromes similar to Lennox-Gastaut syndrome. Expand
Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families
TLDR
To identify causative mutations of Lennox-Gastaut syndrome, the whole-exome sequencing data of 17 unrelated Korean families, including patients with LGS and LGS-like epilepsy without brain abnormalities, was analyzed using the Genome Analysis Toolkit and 14 mutations in 14 genes were identified as causes. Expand
Expert opinion: Proposed diagnostic and treatment algorithms for Lennox–Gastaut syndrome in adult patients
TLDR
The LGS diagnostic algorithm recommends that clinicians consider the occurrence of wider seizure types and abnormal EEG activities to be potentially indicative of LGS, and should be frequently revisited to incorporate improved techniques and therapies. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 90 REFERENCES
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology
TLDR
The main issues with regard to the diagnosis and treatment options available are discussed and the importance of a comprehensive approach to the assessment and management of this syndrome is highlighted. Expand
Definition and natural history of Lennox‐Gastaut syndrome
Lennox‐Gastaut syndrome (LGS) is a rare epileptic encephalopathy with a peak age of onset of 3–5 years of age. Reported prevalence rates for LGS vary widely from 1–10% of all childhood epilepsies.Expand
Update on the management of Lennox-Gastaut syndrome.
TLDR
Although large lobar resections are often required, very localized, discrete resections may be possible, as in symptomatic Lennox-Gastaut syndrome (specifically, hypothalamic hamartoma), and the history of the disease and current management options are reviewed. Expand
Medical management of Lennox-Gastaut syndrome
TLDR
An improvement in the management of Lennox-Gastaut syndrome requires a better understanding of the pathophysiology of this disorder and the development of animal models in which to test new compounds. Expand
Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome
TLDR
Rufinamide was an effective and well-tolerated treatment for seizures associated with Lennox–Gastaut syndrome and had a greater improvement in seizure severity than placebo. Expand
Nonconvulsive status epilepticus--a possible cause of mental retardation in patients with Lennox-Gastaut syndrome.
TLDR
The data provide an indirect evidence that, at least in some of the patients, NCSE is not only a concomitant feature, but also a cause of severe mental retardation in patients with LGS. Expand
Lennox-Gastaut Syndrome
TLDR
It is shown that Lennox-Gastaut syndrome is one of the most difficult epilepsy syndromes to treat and is frequently resistant to treatment with standard antiepilepsy drugs. Expand
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
TLDR
Emerging evidence suggests that complete callosotomy provides greater improvement in seizures without additional side effects, and cannabidiol has emerged as a promising investigational therapy with vast social interest yet lacks a standard, approved formulation. Expand
Lennox gastaut syndrome, review of the literature and a case report
TLDR
Clinical findings in Lennox-Gastaut syndrome included facial deformities, periodontitis and gingival swellings, but prevention of periodontal and dental diseases is preferable for this high-risk group of patients. Expand
An atypical case of Lennox-Gastaut syndrome not associated with mental retardation: A nosological issue
TLDR
The case of a 28-year-old woman who developed AAS and brief asymmetric TS at the age of 14 years, whose seizure disorder met diagnostic criteria for LGS, but there was no intellectual impairment and an interictal alpha EEG. Expand
...
1
2
3
4
5
...